Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1/2 2Phase 4 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Breast Neoplasms 2Vitamin D Deficiency 1Rectal Neoplasms 1Insulin Resistance 1Inflammation 1Giant Cell Tumor of Bone 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cognitive Dysfunction 1Bone Diseases 1Biomarker Change Linked to Breast Cancer 1

Interventions

cetrorelix 2Vitamin D 2Metformin 2Chorionic Gonadotropin 2mazdutide 1drospirenone and ethinyl estradiol combination 1Triptorelin Pamoate 1Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination 1Sitagliptin Phosphate 1Secretome 1Rehydration Solutions 1Menotropins 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Gonadotropins 1Glucagon-Like Peptide-1 Receptor 1Folic Acid 1Diet 1Clomiphene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Polycystic Ovary Syndrome × Vitamin D × Clear all
NCT04916925 2021-06-08

Effect of Vitamin D Oral Supplementation in Poly Csytic Ovarian Women Resistant to Clomiphene Citrate

Ain Shams University

Phase 1/2 Unknown
100 enrolled

Polycystic Ovary Syndrome, Vitamin D Deficiency

NCT00907153 2017-12-19

Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS)

Milton S. Hershey Medical Center

Phase 1/2 Completed
36 enrolled 44 charts

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡